Searched for
BAYER NEWS
Nova Scotia Crime: Woman charged with attempted murder after alleged stabbing in Halifax; what do we know so farNova Scotia News: Halifax police are investigating two serious incidents. A woman faces attempted murder charges following a weekend stabbi...- Bayer to buy Perfuse Therapeutics in up to $2.45 billion dealBayer is set to acquire Perfuse Therapeutics in a deal valued up to $2.45 billion. This strategic move aims to enhance Bayer's eye care tre...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Positive on market in 2025; start nibbling into FMCG stocks: Sandip SabharwalFMCG stocks: Sandip Sabharwal advises a 'nibble and buy' strategy for FMCG stocks, emphasizing their long-term value and potential for gain...
- Bayer acquires remaining 25% stake in Bayer Zydus Pharma Pvt Ltd to secure full ownershipBayer Pharmaceuticals Private Limited and Zydus Lifesciences Limited have concluded their joint venture, Bayer Zydus Pharma Private Limited...
- Buy Bayer Cropscience, target price Rs 6500: Anand RathiBayer Cropscience Ltd., incorporated in the year 1958, is a Mid Cap company (having a market cap of Rs 24951.18 Crore) operating in Pestici...
- German pharma major Bayer stops business in Pakistan: ReportBayer, one of the world's biggest pharmaceutical firms, is closing its business in Pakistan in the wake of a protest from local employees w...
- Bayer's consumer health unit plans to step up India playIn an interview to ET, Sandeep Verma, country head, India, Bayer consumer health division in India, said the company will use its global ex...
- Bayer CropScience zooms 7% as Q4 PAT surges over two-foldIn the fourth quarter of 2021-22, the company's revenue from operations witnessed a growth of 31.29 per cent to Rs 963.3 crore compared wit...
- Stocks in the news: Airtel, Colgate, Tata Power, Lupin, Coforge and Bayer CropThe telecom major Bharti Airtel has acquired around a 9 per cent stake in renewable energy firm Avaada Clean TN Project for about Rs 7.88 c...
- Europe drought negative for UPL, says CIMBCIMB said rainfall in Europe is at a multi-year low and heatwaves are prevalent.
- Bayer bullish on India, but Monsanto’s image remains a challengeBayer’s Indian operations already include a crop science segment, which is involved in crop protection, seeds and what it calls “digital fa...
- Monsanto earnings disappointment may help Bayer with its bidMonsanto posted lower-than-estimated profit and sales for its fiscal third quarter as it faces lower farmer spending amid weak agricultural...
- Germany’s Bayer exploring takeover bid for MonsantoThe German firm has held preliminary discussions internally and with advisers about buying Monsanto, which has a market value of almost $40...
- Little support for pharma MNCs on patent issueThe flexibilities are there and they have never been questioned by anyone in the WTO.
- Natco’s compulsory licence for selling generic copies of Bayer’s cancer drug Nexavar upheld by IpabThe Indian patents appeals board had last year dismissed Bayer’s petition seeking a stay on the “compulsory licence” issued to Natco.
- Natco Pharma bags licence to sell Bayer's cancer drug NexavarThe government has allowed a local drugmaker Natco Pharma to make and sell a patented cancer drug at a fraction of the price charged by Ger...
- Sun Pharma up 3% on bourses on news of tie up with US drug coShares of Sun Pharma touched Rs 455.90, a jump of 3 per cent over its previous closing price on the Bombay Stock Exchange.
- GSK to offer $15 bn for Pfizer unit: reportThe British-based pharmaceutical group GlaxoSmithKline (GSK) is planning to offer more than $15 billion dollars for the consumer health car...
Load More
